98%
921
2 minutes
20
Objective: Although magnetic resonance-guided focused ultrasound (MRgFUS) at the ventral intermediate (VIM) thalamic nucleus is a novel and effective treatment for medication-refractory essential tremor (ET), it is unclear how the ablation lesion affects functional activity. The current study sought to evaluate the functional impact of MRgFUS thalamotomy in patients with ET, as well as to investigate the relationship between neuronal activity changes and tremor control.
Methods: This study included 30 patients with ET who underwent MRgFUS thalamotomy with a 6-month follow-up involving MRI and clinical tremor rating. Additional sex- and age-matched healthy people were recruited for the healthy control group. The fractional amplitude of low-frequency fluctuation (fALFF) and regional homogeneity were used to identify functional alteration regions of interest (ROIs). To investigate changes after treatment, ROI- and seed-based functional connectivity (FC) analyses were performed.
Results: Patients with ET had significantly increased fALFF in the right postcentral gyrus (PoCG; ROI 1), regional homogeneity in the left PoCG (ROI 2), and regional homogeneity in the right PoCG (ROI 3, cluster-level p value family-wise error [pFWE] < 0.05), which were recovered and normalized at 6 months after MRgFUS thalamotomy. FCs between ROI 2 and the right supramarginal gyrus, ROI 2 and the right superior parietal gyrus, and ROI 3 and the left precentral gyrus were also found to be increased after treatment (cluster-level pFWE < 0.05). Furthermore, changes in fALFF, regional homogeneity, and FC values were significantly correlated with tremor relief (p < 0.05). Preoperative FC strengths were found to be inversely related to the postoperative tremor control ratio (p < 0.05).
Conclusions: In patients with ET, the VIM lesion of MRgFUS thalamotomy resulted in symptom-related regional functional recovery associated with sensorimotor and attention networks. Preoperative FC strengths may reflect the postoperative tremor control ratio, implying that this metric could be a useful neuroimaging biomarker for predicting symptom relief in patients with ET following thalamotomy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3171/2022.9.FOCUS22228 | DOI Listing |
Eur J Neurol
September 2025
Neuroscience and Brain Disease Center, China Medical University, Taichung, Taiwan.
Background: Stepwise dual-target MR-guided Focused Ultrasound (dtMRgFUS) is a novel treatment for Parkinson's disease (PD), targeting both Ventral Intermediate Nucleus (VIM) and the pallidothalamic tract (PTT). While previous studies have demonstrated its 12-month efficacy, this study focuses on the immediate effects of additional PTT lesioning after VIM ablation.
Methods: Twenty patients (age 69.
J Neurosurg Case Lessons
August 2025
Department of Neurosurgery, Texas Children's Hospital/ Baylor College of Medicine, Houston, Texas.
Background: Neuropathic cancer pain (NCP) is a debilitating condition that is often refractory to conventional medical management. MRI-guided focused ultrasound (MRgFUS) central lateral thalamotomy (CLT) is an incisionless neurosurgical option for neuropathic pain palliation, but its use in pediatric patients and those with cranial metastases, a relative contraindication to MRgFUS, remains largely unexamined.
Observations: A 16-year-old male with metastatic rhabdomyosarcoma (RMS) with numerous cranial metastases experienced severe, diffuse, refractory NCP.
Mov Disord
August 2025
Clinical Functional Imaging Group, Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Precise targeting in magnetic resonance-guided focused ultrasound (MRgFUS) is critical for effective tremor control in essential tremor and tremor-dominant Parkinson's disease, as small deviations can reduce efficacy or cause side effects. In our cohort, sweetspots were identified at Montreal Neurological Institute (MNI) coordinates x = -12.4, y = -17.
View Article and Find Full Text PDFClin Park Relat Disord
July 2025
Department of Radiology, The First Medical Center of Chinese PLA General Hospital, No.28 Fuxing Road, Beijing 100853, China.
Introduction: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is safe and effective for tremor disorders such as essential tremor (ET), but whether preoperative serum profiles mediate tremor recurrence after treatment requires further investigation.
Methods: We retrospectively analyzed the data of 59 ET patients who underwent unilateral MRgFUS thalamotomy during 2018-2020. Tremor severity was assessed off-medication using the Clinical Rating Scale for Tremor (CRST), with contralateral hand tremor measured via a derived CRST subscale.
BMJ Neurol Open
July 2025
UCL Functional Neurosurgery Unit, National Hospital for Neurology and Neurosurgery, London, UK.
Background And Objective: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy of the ventral intermediate nucleus (Vim) is an effective therapy for medication-refractory essential tremor (ET). The Vim is not readily visualised on conventional MRI and targeting is routinely performed indirectly, with atlas co-ordinates. Inaccurate targeting due to interindividual anatomical variability can result in side effects and reduced efficacy.
View Article and Find Full Text PDF